Abstract

A confirmed case of 41-year-old male with T-cell precursor acute lymphoblastic leukemia was inducted to BFM 2002 protocol, induction phase 1 (this protocol includes injection daunorubicin, vincristine, L-asparaginase with triple intrathecal injection of methotrexate, cytosine, hydrocortisone, and oral prednisolone). The patient complained of epigastric pain with hepatosplenomegaly and laboratory investigation revealed deranged lipid profile with hypertriglyceridemia (HTG) as a major feature and hyperbilirubinemia and raised transaminase. He was diagnosed with a case of HTG with acute pancreatitis, a complication, due to L-asparaginase. Initially, his condition was treated with medical management, but reduction in triglyceride (TG) level was not as expected. It was decided then to manage the case with concomitant therapeutic plasma exchange therapy. One exchange not only reduced the TG level drastically but also the bilirubin level and the patient recovered and was able to start the next phase of the protocol.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.